Workflow
Artificial Intelligence
icon
搜索文档
POET Technologies Reports Second Quarter 2025 Financial Results
GlobeNewswire News Room· 2025-08-12 05:00
TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today reported its unaudited condensed consolidated financial results for the second quarter ended June 30, 2025. The Company’s financial results as well as the Management Discussion and Analysis have been filed on SEDAR+. All financial figures are ...
Heartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Globenewswire· 2025-08-12 04:30
IPO发行情况 - 公司完成增发后的首次公开募股(IPO),共发行19,166,667股普通股,每股发行价为19美元,其中包含承销商全额行使超额配售权购买的2,500,000股 [1] - 扣除承销折扣和佣金前,总募集资金约为3.642亿美元 [1] - 公司股票于2025年8月8日在纳斯达克全球精选市场上市,交易代码为"HTFL" [1] - 摩根大通、摩根士丹利和Piper Sandler担任联合账簿管理人,Stifel和Canaccord Genuity担任联席管理人 [1] 公司业务与技术 - 公司专注于冠状动脉疾病(CAD)的AI技术,致力于将其转化为可筛查、可诊断和可管理的疾病 [4] - Heartflow One是目前唯一完整的非侵入性精准冠状动脉护理平台,覆盖指南推荐的CCTA路径全流程 [4] - 平台包含Roadmap™分析、FFRCT分析和斑块分析三大AI驱动模块,获得ACC/AHA胸痛指南支持 [4] - 技术已获600多篇同行评审论文验证,全球累计服务超过40万患者 [4] 法律与监管 - 本次发行相关注册声明已获美国证券交易委员会(SEC)批准生效 [2] - 招股说明书可通过指定渠道获取,包括摩根大通、摩根士丹利和Piper Sandler的特定联系方式 [2]
BigBear.ai(BBAI) - 2025 Q2 - Earnings Call Presentation
2025-08-12 04:30
Investor Presentation Second Quarter 2025 Kevin McAleenan CHIEF EXECUTIVE OFFICER, BOARD MEMBER Sean Ricker CHIEF FINANCIAL OFFICER Forward Looking Statements This presentation contains forward-looking statements regarding future events and our future results that are subject to the safe harbors created under the Securities Act of 1933 (the "Securities Act"), the Securities Exchange Act of 1934 (the "Exchange Act") and the Private Securities Litigation Reform Act of 1995. Forward-looking statements generall ...
Apollo Funds Reach Agreement with American Securities to Acquire Trace3, a Leading Technology Solutions Provider Driving Adoption of Next-Generation Technology and AI
Globenewswire· 2025-08-12 04:30
Strategic Investment to Accelerate Trace3’s Growth and Expand Solutions Across Security, Hybrid Cloud and AIIRVINE, Calif. and NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that funds managed by its affiliates (the “Apollo Funds”) have agreed to acquire Trace3, a leading provider of enterprise and commercial technology solutions, from American Securities. Financial terms were not disclosed. American Securities will retain a significant minority equity interest in the company ...
Heartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
GlobeNewswire News Room· 2025-08-12 04:30
MOUNTAIN VIEW, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its upsized initial public offering of 19,166,667 shares of its common stock at a public offering price of $19 per share, which includes 2,500,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares. All of the shares of common stock were offered by ...
PubMatic(PUBM) - 2025 Q2 - Earnings Call Presentation
2025-08-12 04:30
Q2 2025 Earnings Presentation August 11, 2025 S A F E H A R B O R This presentation contains forward-looking statements regarding our future business expectations, including but not limited to our guidance relating to our revenue, adjusted EBITDA, and adjusted EBITDA margin for the third quarter of 2025 and capex for the full year 2025, our expectations regarding our free cash flow, capital expenditures, future hiring, future market growth, our long-term revenue growth and our ability to gain market share. ...
Perimeter Announces Preliminary Unaudited Revenues for the 2025 Second Quarter; Reduces Operating Costs by ~30% as Company Focuses on Commercial Sales Pipeline and Growth Opportunities
Prnewswire· 2025-08-12 04:15
– Webcasted Q2-2025 conference call scheduled for August 26th at 5:00 PM EDT –TORONTO and DALLAS, Aug. 11, 2025 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced preliminary unaudited revenues for the second quarter ended June 30, 2025, senior management changes, and the creation of a Perimeter Industry Advisory Board ("IAB").Preliminary Unaudited Second Quarter 2025 Revenues Unless oth ...
Azitra, Inc. Announces Reverse Stock Split
Prnewswire· 2025-08-12 04:15
Common Stock Will Begin Trading on a Split-Adjusted Basis on August 21, 2025BRANFORD, Conn., Aug. 11, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 6.66 pre-split shares. The reverse stock split will become effective at 12:01 A.M. Eastern Time, on August 21, 20 ...
Getty Images Reports Second Quarter 2025 Results
Globenewswire· 2025-08-12 04:07
Q2 Revenue Growth of 2.5%, Currency Neutral Growth of 1.8%Q2 Annual Subscription Revenue Growth of 3.7%, Currency Neutral 3.0%Annual Subscription Revenue Rose to 53.5% of Total Revenue in Q2Reaffirms 2025 Revenue and Adjusted EBITDA Guidance NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. (“Getty Images” or the “Company”) (NYSE: GETY), a preeminent global visual content creator and marketplace, today reported financial results for the second quarter ended June 30, 2025. “We delivered ...
Metagenomi Appoints Laurence Reid, PhD to its Board of Directors
Globenewswire· 2025-08-12 04:05
Dr. Reid brings 30 years of experience in building biotech companies based on innovative scientific platforms and shaping pipeline and business strategyEMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX) (the “Company”), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today announced the appointment of Laurence Reid, PhD, to its Board of Directors. “We are delighted to welcome Dr. Re ...